Literature DB >> 28569377

Testing for Noonan syndrome after increased nuchal translucency.

Marwan M Ali1, Stephen T Chasen1, Mary E Norton2.   

Abstract

OBJECTIVE: The aim of this study was to report the prevalence of Noonan syndrome (NS) in a cohort of fetuses that presented with increased nuchal translucency (NT) thickness in the first trimester of pregnancy.
METHODS: This is a retrospective chart review. INCLUSION CRITERIA: (1) first trimester NT measurement ≥3 mm, (2) normal karyotype by either a CVS or an amniocentesis procedure, and (3) prenatal molecular genetic testing for NS completed. Results with known pathogenic variants were considered positive, while those with variants of unknown clinical significance, or with no variants, were considered negative.
RESULTS: A total of 804 fetuses had an NT measurement of ≥3 mm, with a median NT thickness of 3.6 mm. Of these, 302 had karyotyping by CVS or amniocentesis, 200 (66.23%) with normal results. Of fetuses with a normal karyotype, 39 with a median NT thickness of 4.0 mm had a NS gene sequencing panel done, and 161 fetuses with a mean NT thickness of 4.3 mm were not tested for NS (p = 0.05). Of the 39 fetuses who were tested for NS, four (10.3%) had variants consistent with this diagnosis.
CONCLUSION: In euploid fetuses, increased NT is associated with a 10% risk of NS.
© 2017 John Wiley & Sons, Ltd. © 2017 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28569377     DOI: 10.1002/pd.5076

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  5 in total

Review 1.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

2.  Prenatal Diagnostic Value of Chromosomal Microarray in Fetuses with Nuchal Translucency Greater than 2.5 mm.

Authors:  Zhu Zhang; Ting Hu; Jiamin Wang; Qinqin Li; He Wang; Shanling Liu
Journal:  Biomed Res Int       Date:  2019-10-03       Impact factor: 3.411

Review 3.  Further delineation of the clinical spectrum of KAT6B disorders and allelic series of pathogenic variants.

Authors:  Li Xin Zhang; Gabrielle Lemire; Claudia Gonzaga-Jauregui; Sirinart Molidperee; Carolina Galaz-Montoya; David S Liu; Alain Verloes; Amelle G Shillington; Kosuke Izumi; Alyssa L Ritter; Beth Keena; Elaine Zackai; Dong Li; Elizabeth Bhoj; Jennifer M Tarpinian; Emma Bedoukian; Mary K Kukolich; A Micheil Innes; Grace U Ediae; Sarah L Sawyer; Karippoth Mohandas Nair; Para Chottil Soumya; Kinattinkara R Subbaraman; Frank J Probst; Jennifer A Bassetti; Reid V Sutton; Richard A Gibbs; Chester Brown; Philip M Boone; Ingrid A Holm; Marco Tartaglia; Giovanni Battista Ferrero; Marcello Niceta; Maria Lisa Dentici; Francesca Clementina Radio; Boris Keren; Constance F Wells; Christine Coubes; Annie Laquerrière; Jacqueline Aziza; Charlotte Dubucs; Sheela Nampoothiri; David Mowat; Millan S Patel; Ana Bracho; Francisco Cammarata-Scalisi; Alper Gezdirici; Alberto Fernandez-Jaen; Natalie Hauser; Yuri A Zarate; Katherine A Bosanko; Klaus Dieterich; John C Carey; Jessica X Chong; Deborah A Nickerson; Michael J Bamshad; Brendan H Lee; Xiang-Jiao Yang; James R Lupski; Philippe M Campeau
Journal:  Genet Med       Date:  2020-05-19       Impact factor: 8.822

4.  Analysis of copy number variation by sequencing in fetuses with nuchal translucency thickening.

Authors:  Liubing Lan; Heming Wu; Lingna She; Bosen Zhang; Yanhong He; Dandan Luo; Huaxian Wang; Zhiyuan Zheng
Journal:  J Clin Lab Anal       Date:  2020-04-27       Impact factor: 2.352

Review 5.  The current state of prenatal detection of genetic conditions in congenital heart defects.

Authors:  Tina O Findley; Hope Northrup
Journal:  Transl Pediatr       Date:  2021-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.